A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The FDA approved Gilead’s landmark long-acting HIV treatment lenacapavir Wednesday afternoon. The drug will be marketed under ...

Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.

New data from GoodRx Research reveals just how inadequate and restrictive prescription insurance has become. Medicaid, often ...

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...

“With the chronic nature of HIV and the risk of resistance, supporting patients in overcoming the challenges that accompany long-term medication adherence through cotailored approaches should ...

We are dying!” the group chanted. The protesters risked being shunned by society to warn that Haiti is running out of HIV medication just months after the Trump administration slashed more than ...

We are dying!” the group chanted. The protesters risked being shunned by society to warn that Haiti is running out of HIV medication just months after the administration of U.S. President Donald ...